Home › Funds › DRIEHAUS CAPITAL MANAGEMENT LLC › KYMR

DRIEHAUS CAPITAL MANAGEMENT LLC position in KYMR

KYMERA THERAPEUTICS INC · Health Care

DRIEHAUS CAPITAL MANAGEMENT LLC reported holding 919,233 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$105.4M, representing 0.61% of its reported portfolio and ranking #45 among its reported holdings. DRIEHAUS CAPITAL MANAGEMENT LLC has disclosed KYMR holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)919.23K sh
Reported value held$105.41M
Portfolio Weight0.61%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DRIEHAUS CAPITAL MANAGEMENT LLC's KYMR position evolved

DRIEHAUS CAPITAL MANAGEMENT LLC first disclosed a stake in KYMR in Q2 2024 at 223,413 shares (US$6.7M). The position peaked in Q2 2026 at 919,233 shares, worth US$105.4M. Across 9 filings, DRIEHAUS CAPITAL MANAGEMENT LLC increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 919,233 shares valued at US$105.4M — a reduction of -124,350 shares quarter over quarter.. Notable position changes include a 495% increase in Q3 2024 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 223.41K $6.67M New
Q3 2024 1.33M $62.89M Add
Q4 2024 1.39M $55.93M Add
Q1 2025 1.17M $31.99M Reduce
Q2 2025 933.89K $40.75M Reduce
Q3 2025 939.09K $53.15M Add
Q4 2025 1.07M $83.20M Add
Q1 2026 1.04M $86.92M Reduce
Q2 2026 919.23K $105.41M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KYMR and 13F data

KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 57 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KYMR

All KYMR fund holders →

FAQ

How long has DRIEHAUS CAPITAL MANAGEMENT LLC held KYMR?

DRIEHAUS CAPITAL MANAGEMENT LLC has disclosed KYMR holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is DRIEHAUS CAPITAL MANAGEMENT LLC's current position in KYMR?

As of Q2 2026, DRIEHAUS CAPITAL MANAGEMENT LLC holds 919.23K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $105.41M, representing 0.61% of its reported portfolio and ranking #45.

Has DRIEHAUS CAPITAL MANAGEMENT LLC been buying or selling KYMR?

In the latest 13F filing (Q2 2026), DRIEHAUS CAPITAL MANAGEMENT LLC reduced its position in KYMR. The position peaked in Q2 2026 at 919.23K shares.

Which other funds hold KYMR?

Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.